TFE3 and neoplasm: In vivo, subcutaneous xenografts generated by mixing tumor cells with P4+TFE3+ CAF or TFE3‐knockdown counterparts (1:2 ratio) demonstrated a significantly increased tumor volume for the P4+TFE3+ group compared to controls (Figure 4D).